-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Initiates Coverage On Immunome with Hold Rating, Announces Price Target of $24

Benzinga·10/01/2026 10:53:49
Listen to the news
Stifel analyst Dara Azar initiates coverage on Immunome (NASDAQ:IMNM) with a Hold rating and announces Price Target of $24.